First Oral Weight-Loss Pill Approved for Sale in Israel
Translated & summarized from Ynet by baba
Israel will become the fourth country to offer a new oral weight-loss pill, Pounaduo, starting September 15. The Eli Lilly drug offers a convenient alternative to injectable GLP-1 agonists, showing an average 12.4% weight loss in studies.
The story in 5 lines · by baba
- First oral weight-loss pill launches in Israel September 15.
- Drug is from GLP-1 agonist class, made by Eli Lilly.
- Israel is the fourth country to offer the pill.
- Studies show average 12.4% weight loss.
- Pill offers convenience over injections, no fasting or refrigeration needed.
A new oral weight-loss medication, the first of its kind in Israel, will be available in pharmacies starting September 15. The drug, called Pounaduo (orforglipron) and manufactured by Eli Lilly, belongs to the GLP-1 receptor agonist class, previously only available via injection.
Israel will be the fourth country globally to offer the pill commercially, following the United States, the United Kingdom, and the United Arab Emirates. Clinical studies showed that the medication led to an average weight loss of 12.4%. While this is a lower average reduction compared to leading injectable GLP-1 agonists, the pill offers the convenience of not requiring fasting or refrigeration.
The drug's arrival marks a significant development in the accessibility of weight-loss treatments in Israel, providing a new option for individuals seeking to manage their weight.
The same event, reported separately by each outlet. Open a few to compare what different newsrooms emphasize — and what they leave out.
Centre 7Right 1Other 1
Not the same event — other stories that share this one’s people, places, or theme: background, reactions, and follow-ups.